Table III.
Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
Variables | n | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex | 0.672 (0.486–1.485) | 0.509 | |||
Male | 34 | ||||
Female | 26 | ||||
Age (years) | 0.537 (0.389–1.059) | 0.543 | |||
<50 | 28 | ||||
≥50 | 32 | ||||
Tumor size (cm) | 0.473 (0.571–1.839) | 0.005 | 0.634 (1.007–2.310) | 0.013 | |
≤5 | 27 | ||||
>5 | 33 | ||||
AFP (ng/ml) | 1.539 (1.409–2.847) | 0.733 | |||
≤20 | 27 | ||||
>20 | 33 | ||||
HBsAg | 1.003 (0.984–1.530) | 0.527 | |||
Positive | 37 | ||||
Negative | 23 | ||||
TNM stage | 1.219 (0.347–1.595) | 0.010 | 1.180 (1.038–2.641) | 0.015 | |
I/II | 27 | ||||
III/IV | 33 | ||||
Multiplicity | 0.495 (0.671–1.734) | 0.034 | 0.834 (0.734–1.995) | 0.027 | |
Single | 24 | ||||
Multiple (≥2) | 36 | ||||
Vascular invasion | 1.045 (1.048–3.618) | 0.649 | |||
Presence | 27 | ||||
Absence | 33 | ||||
Liver cirrhosis | 1.217 (1.257–2.804) | 0.806 | |||
Presence | 32 | ||||
Absence | 28 | ||||
Intrahepatic metastasis | 0.673 (0.758–2.645) | 0.587 | |||
Presence | 25 | ||||
Absence | 35 | ||||
miR-29c-3p expression | 1.148 (0.687–1.694) | 0.019 | 1.327 (1.224–2.647) | 0.014 | |
Low | 39 | ||||
High | 21 |
RFS, recurrence-free survival; HCC, hepatocellular carcinoma.